• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化基质金属蛋白酶-9对血小板活化的抑制机制。

Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.

作者信息

Lee Ye-Ming, Lee Jie-Jen, Shen Ming-Yi, Hsiao George, Sheu Joen-Rong

机构信息

Department of Surgery, Hsinchu Mackay Memorial Hospital, Hsinchu, Taiwan.

出版信息

Eur J Pharmacol. 2006 May 10;537(1-3):52-8. doi: 10.1016/j.ejphar.2006.03.031. Epub 2006 Mar 17.

DOI:10.1016/j.ejphar.2006.03.031
PMID:16624282
Abstract

The intracellular mechanisms underlying the signaling pathways of activated matrix metalloproteinase-9 (MMP-9) in platelets are not yet completely understood. Therefore, the aim of this study was to further examine the effects of activated MMP-9 in preventing platelet aggregation. In this study, activated MMP-9 time-dependently (3-60 min) inhibited platelet aggregation in washed human platelet suspensions stimulated by agonists. However, activated MMP-9 had no significant effect on the binding of FITC-triflavin to the platelet glycoprotein IIb/IIIa complex. Triflavin is a specific antagonist of the glycoprotein IIb/IIIa complex purified from snake venom. Moreover, activated MMP-9 (21 and 90 ng/ml) markedly decreased the fluorescence intensity of platelet membranes tagged with diphenylhexatriene. The thrombin-evoked increase in pHi was inhibited in the presence of activated MMP-9 (21 and 90 ng/ml). In addition, activated MMP-9 (21 and 90 ng/ml) markedly reduced the electron spin resonance (ESR) signal intensity of hydroxyl radicals in collagen (1 mug/ml)-activated platelets. These results indicate that the antiplatelet activity of activated MMP-9 may involve the following pathways: (1) activated MMP-9 may initially induce conformational changes in platelet membranes and hydroxyl radical formation, leading to inhibition of platelet aggregation; and (2) activated MMP-9 also inhibits the Na(+)/H(+) exchanger, leading to reduced intracellular Ca(2+) mobilization, and ultimately to inhibition of platelet aggregation. This study further provides new insights concerning the effects of activated MMP-9 on platelet aggregation.

摘要

血小板中活化基质金属蛋白酶-9(MMP-9)信号通路的细胞内机制尚未完全明确。因此,本研究旨在进一步探究活化MMP-9在预防血小板聚集方面的作用。在本研究中,活化MMP-9在3 - 60分钟内呈时间依赖性地抑制了激动剂刺激的洗涤人血小板悬液中的血小板聚集。然而,活化MMP-9对异硫氰酸荧光素-三黄素与血小板糖蛋白IIb/IIIa复合物的结合没有显著影响。三黄素是从蛇毒中纯化得到的糖蛋白IIb/IIIa复合物的特异性拮抗剂。此外,活化MMP-9(21和90 ng/ml)显著降低了用二苯基己三烯标记的血小板膜的荧光强度。在存在活化MMP-9(21和90 ng/ml)的情况下,凝血酶引起的细胞内pH值升高受到抑制。另外,活化MMP-9(21和90 ng/ml)显著降低了胶原蛋白(1 μg/ml)激活的血小板中羟基自由基的电子自旋共振(ESR)信号强度。这些结果表明,活化MMP-9的抗血小板活性可能涉及以下途径:(1)活化MMP-9可能首先诱导血小板膜的构象变化和羟基自由基的形成,从而导致血小板聚集的抑制;(2)活化MMP-9还抑制钠/氢交换体,导致细胞内钙离子动员减少,最终抑制血小板聚集。本研究进一步为活化MMP-9对血小板聚集的作用提供了新的见解。

相似文献

1
Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.活化基质金属蛋白酶-9对血小板活化的抑制机制。
Eur J Pharmacol. 2006 May 10;537(1-3):52-8. doi: 10.1016/j.ejphar.2006.03.031. Epub 2006 Mar 17.
2
Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation.低浓度氧化型低密度脂蛋白对血小板聚集的抑制机制
J Biomed Sci. 2006 May;13(3):333-43. doi: 10.1007/s11373-005-9042-x. Epub 2005 Nov 9.
3
Mechanism involved in the antiplatelet activity of naloxone in human platelets.纳洛酮对人血小板抗血小板活性的作用机制。
Biochem Biophys Res Commun. 1997 Feb 3;231(1):12-6. doi: 10.1006/bbrc.1996.6037.
4
C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.C-藻蓝蛋白,一种来自钝顶螺旋藻的非常有效的新型血小板聚集抑制剂。
J Agric Food Chem. 2005 Oct 5;53(20):7734-40. doi: 10.1021/jf051352y.
5
Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.基质金属蛋白酶-9在人血小板中的表达:体外和体内研究中血小板活化的调节
Br J Pharmacol. 2004 Sep;143(1):193-201. doi: 10.1038/sj.bjp.0705917. Epub 2004 Aug 2.
6
alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.α-萘黄酮是一种有效的抗血小板类黄酮,其作用是通过抑制磷脂酶C的活性和刺激环鸟苷酸的形成来介导的。
J Agric Food Chem. 2005 Jun 29;53(13):5179-86. doi: 10.1021/jf0500738.
7
Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.新型酪氨酸激酶抑制剂3,4-亚甲二氧基-β-硝基苯乙烯对血小板糖蛋白IIb/IIIa激活的预防作用
Mol Pharmacol. 2006 Oct;70(4):1380-9. doi: 10.1124/mol.106.023986. Epub 2006 Jul 12.
8
Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.金黄色葡萄球菌脂磷壁酸对人血小板抗血小板活性的作用机制。
Thromb Haemost. 2000 May;83(5):777-84.
9
Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies.咪达唑仑在体外和体内研究中的抗血小板和抗血栓形成活性机制。
Eur J Pharmacol. 2004 Mar 8;487(1-3):159-66. doi: 10.1016/j.ejphar.2004.01.026.
10
Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.芦丁(黄酮醇槲皮素的一种糖苷)在人血小板中的抗血小板活性所涉及的机制。
J Agric Food Chem. 2004 Jul 14;52(14):4414-8. doi: 10.1021/jf040059f.

引用本文的文献

1
Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.基于基因表达综合数据库鉴定脓毒症的关键致病基因。
Mol Med Rep. 2018 Feb;17(2):3042-3054. doi: 10.3892/mmr.2017.8258. Epub 2017 Dec 12.
2
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.脓毒症相关死亡率与TIMP-1/MMP-9比值早期升高的关联。
PLoS One. 2014 Apr 11;9(4):e94318. doi: 10.1371/journal.pone.0094318. eCollection 2014.
3
The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.
TIMP-1基因的372 T/C基因多态性与严重脓毒症患者的TIMP-1血清水平及生存率相关。
Crit Care. 2013 May 25;17(3):R94. doi: 10.1186/cc12739.
4
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.基质金属蛋白酶-9、-10 和基质金属蛋白酶组织抑制剂-1 的血液水平作为脓毒症严重程度和死亡率的生物标志物。
Crit Care. 2009;13(5):R158. doi: 10.1186/cc8115. Epub 2009 Oct 2.